Apr 19, 2023 | Articles, Clinical Trials
NAVIGATING REGULATORY APPROVAL WITH A CRO IN IVD DEVELOPMENT The development and commercialization of medical devices, including diagnostics, require a significant investment of time, resources, and expertise. To navigate the complex regulatory approval process and...
Aug 18, 2021 | Antibody, Articles, CLIA, COVID-19, News and Events
By Abby Kousouris Published: Aug. 17, 2021 at 7:25 PM EDT KNOXVILLE, Tenn. (WVLT) – A local Knoxville company says they’re seeing more demand for COVID-19 testing. EDP Biotech Corporation has different options available for people who want to find out if they...
Apr 14, 2021 | Articles, CLIA, ColoPlex, Colorectal Cancer, Company Details, COVID-19, Featured, News and Events
EDP Biotech Finalist in MedCity INVEST Pitch Perfect Diagnostic Track In the age of COVID, diagnostics have become more valuable than ever. EDP Biotech has been fortunate to advance diagnostic programs in colorectal cancer and COVID testing during the last year, and...
Mar 2, 2021 | Articles, Clinical Trials, COVID-19, Featured, News and Events
INSFRASTRUCTURE, TECHNOLOGY AND REGULATION FOR DCTs In this presentation, we discuss how decentralized clinical trials provide better patient engagement by removing common barriers that can have a negative impact on recruitment and retention. We examine various...
Dec 8, 2020 | Articles, ColoPlex, Colorectal Cancer, Company Details, COVID-19, Featured, News and Events
NOLABA, Partners Name Winners of Health Innovators Challenge Watch the YouTube video above to hear EDP Biotech and other NOLABA Challenge winners discuss their impact in healthcare. Read full Article on BizNewOrleans.com “The third challenge was a unique...
Jul 16, 2020 | Antibody, Articles, CLIA, COVID-19, News and Events
EDP Biotech is able to be a testing resource for local employers, thanks to the local company’s designation as a CLIA-certified lab. CLIA stands for the Clinical Laboratory Improvement Amendments of 1988 that established federal regulatory standards applicable to all...
